YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis-Reference-Cited by-同舟云学术

YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis

Published:2021-10-19 Issue:12 Volume:13 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Gao Ruize¹,Kalathur Ravi K R¹,Coto‐Llerena Mairene²,Ercan Caner²^ORCID,Buechel David¹,Shuang Song³,Piscuoglio Salvatore²^ORCID,Dill Michael T⁴⁵,Camargo Fernando D⁴⁵^ORCID,Christofori Gerhard¹^ORCID,Tang Fengyuan¹^ORCID

Affiliation:

1. Department of Biomedicine University of Basel Basel Switzerland

2. Institute of Pathology University Hospital Basel Basel Switzerland

3. Friedrich Miescher Institute for Biomedical Research Basel Switzerland

4. Stem Cell Program Boston Children's Hospital Boston MA USA

5. Department of Stem Cell and Regenerative Biology Harvard University Cambridge MA USA

Funder

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.202114351

Reference39 articles.

1. HMGA1 Expression in Human Hepatocellular Carcinoma Correlates with Poor Prognosis and Promotes Tumor Growth and Migration in in vitro Models

2. Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization

3. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma

4. ATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner

5. High Expression of FAP in Colorectal Cancer Is Associated With Angiogenesis and Immunoregulation Processes

Cited by 285 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Solanum torvum induces ferroptosis to suppress hepatocellular carcinoma;Journal of Ethnopharmacology;2024-12

2. The role of metal ions in stroke: Current evidence and future perspectives;Ageing Research Reviews;2024-11

3. crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancer;Drug Resistance Updates;2024-11

4. ATF family members as therapeutic targets in cancer: From mechanisms to pharmacological interventions;Pharmacological Research;2024-10

5. Ferroptosis: Molecular perspective, cellular influence, cancer manifestation, and therapeutic potentials;Journal of Drug Delivery Science and Technology;2024-10